Tag: neurosoft-bioelectronics

2 articles

Market Moves

Most of Europe's leading neurotechnology companies trace back to one Geneva research campus

The Friday $7.5 million seed round for Neurosoft Bioelectronics is the latest commercial output from a Lausanne-Geneva neurotechnology cluster anchored on EPFL's Neuro-X Institute at Campus Biotech Geneva. The same cluster has produced ONWARD Medical (now NASDAQ-listed brain-spine interface company), MindMaze (Lausanne-founded brain-technology unicorn), and the academic research that China's brain-spine clinical programmes are now structurally copying.

May 26

Industry News

Swiss BCI startup Neurosoft closes $7.5M seed led by Skybound, the first cheque from a new EIF-anchored European deeptech fund

Neurosoft Bioelectronics closed a $7.5 million oversubscribed seed round on 20 May 2026, led by Skybound Venture Capital and joined by PL Capital, IAG Capital Partners, and Connecticut Innovations. The round brings Neurosoft's total funding past $20 million and is the inaugural investment from Skybound, a new Athens-based deeptech fund publicly launched the same week with a $38 million first close anchored by the European Investment Fund.

May 22

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.